These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1058731)

  • 21. Immunotherapy in gram-negative bacterial infections.
    Lugowski C
    Acta Biochim Pol; 1995; 42(1):19-24. PubMed ID: 7653155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid test for endotoxin in whole blood.
    Rylatt D; Wilson K; Kemp BE; Elms MJ; Manickavasagam B; Shi W; Cox A; McArthur MJ; O'Hara J; Corbett ME
    Prog Clin Biol Res; 1995; 392():273-84. PubMed ID: 8524932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approach.
    Falagas ME; Rafailidis PI
    Shock; 2007 Jun; 27(6):605-9. PubMed ID: 17505298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma lysosomal enzymes in experimental and clinical endotoxemia.
    Godin DV; Wright JM; Tuchek JM; Scudamore CH
    Clin Invest Med; 1983; 6(4):319-25. PubMed ID: 6671362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Septic shock in newborn infants].
    Mancilla-Ramírez J
    Bol Med Hosp Infant Mex; 1992 Nov; 49(11):766-76. PubMed ID: 1466777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections.
    Del Pozo JL; Alonso M; Serrera A; Hernaez S; Aguinaga A; Leiva J
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):208-12. PubMed ID: 19026506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of infection risk and the value of urine endotoxin during extracorporeal shock wave lithotripsy.
    Li L; Shen Z; Wang H; Fu S; Cheng G
    Chin Med J (Engl); 2001 May; 114(5):510-3. PubMed ID: 11780415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effects of use polymyxin B fixed on fibers in liver transplant patients with severe sepsis or septic shock.
    Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Perrella S; Cappannoli A; Mazzarino V; Tosi A; Novelli G; Rossi M; Ginanni Corradini S; Ferretti G; Berloco PB; Pietropaoli P
    Transplant Proc; 2007; 39(6):1953-5. PubMed ID: 17692664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
    Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk factors and prognosis of nosocomial pneumonia due to gram-negative bacteria in a general hospital].
    Martínez B; Gómez J; Gómez Vargas J; Gómez JR; Baños V; Sánchez ME; Canteras M; Valdés M
    Rev Esp Quimioter; 2000 Jun; 13(2):187-92. PubMed ID: 10918093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ; Chmel H
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic therapy in current surgical practice.
    Bohnen DR; Rosen IB
    Can Med Assoc J; 1965 Oct; 93(16):854-8. PubMed ID: 5318576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The problem of endotoxin shock after antibiotic therapy in surgery (author's transl)].
    Margreiter R; Salzer GM; Aufschnaiter M; Semenitz E
    Zentralbl Chir; 1978; 103(14):935-7. PubMed ID: 358672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Attempted protection against experimental endotoxic shock].
    Fumarola D; Marcuccio L; Fransvea P; Pasquetto N; Miragliotta G; Brienza A
    G Batteriol Virol Immunol; 1975; 68(7-12):224-30. PubMed ID: 186348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel agents in the therapy of endotoxic shock.
    Howe LM
    Expert Opin Investig Drugs; 2000 Jun; 9(6):1363-72. PubMed ID: 11060748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic-induced release of endotoxin: a reappraisal.
    Hurley JC
    Clin Infect Dis; 1992 Nov; 15(5):840-54. PubMed ID: 1445982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin.
    Schimke J; Mathison J; Morgiewicz J; Ulevitch RJ
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13875-80. PubMed ID: 9811894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of septic shock.
    Eskridge RA
    Drug Intell Clin Pharm; 1983 Feb; 17(2):92-9. PubMed ID: 6337804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.